Latest Impairments News

Infotrust Ltd (ASX: ITS) reported a 9.8% rise in FY26 revenue to $64.1 million, powered by a strategic pivot to cyber security. The company exited its Cloud segment, repaid all bank debt, and acquired Catalyst Cyber to boost federal market presence, positioning for profitable growth in FY27.

Mayfield Childcare’s HY26 results reveal a 6% revenue decline and deepening statutory loss, offset by operational improvements and strategic restructuring.

Activeport Group Ltd’s FY26 results show a 36% revenue decline to $6.15 million and a net loss of $14.7 million, driven by strategic shifts towards recurring software revenue and AI infrastructure orchestration. The company launched its own national network in Australia and expanded internationally with new subsidiaries and leadership hires.

Microba Life Sciences delivered a mixed FY26, with overall revenue slipping 5.8% to $14.76 million and a statutory loss widening 38.7% to $20.7 million. The company’s strategic pivot to core microbiome testing paid off with a 92% surge in core testing revenue and record test volumes in Australia and the UK. Despite the headline loss, underlying loss improved 11% thanks to cost cuts and AI-driven efficiencies. Microba is gearing up for the October launch of its GI Navigator diagnostic and targeting cash flow break-even on a run-rate basis in calendar 2027.

Pengana Global Private Credit Trust (ASX: PCX) reported a solid FY26 with an 8.8% cash distribution yield and stable credit quality despite fair value pressures from widening credit spreads.

Maggie Beer Holdings reported a 60.8% reduction in net loss for FY26 to $9.5 million despite flat sales, driven by margin gains and cost cuts. The company appointed Chris Illman as Managing Director to lead its recovery and growth strategy.

Peak Processing Limited’s FY26 results reveal a doubling loss from continuing operations to $10 million amid a $4.35 million impairment, offset partially by a $2.5 million profit from discontinued operations. The company completed an operational reset and posted its first positive EBITDA quarter in June 2026.

Clever Culture Systems expanded its pharmaceutical customer base to eight in FY26, placing 11 APAS Independence instruments and completing its product offering with a contact plate module. Despite a $2.24 million net loss, the company expects meaningful sales growth in FY27 backed by a robust pipeline and disciplined financial management.

Avecho has resumed enrolment for the last stage of its pivotal Phase III trial of a TPM®-enhanced CBD capsule for insomnia, following a unanimous Data Monitoring Board recommendation to continue without expanding the sample size.

Vinyl Group Ltd lifted revenue by nearly 31% to $18.85 million in FY2026 but continued to post a loss, albeit nearly halved to $8.65 million. The media company expanded aggressively through multiple acquisitions, boosting its asset base and goodwill while maintaining a going concern stance.

Kina Securities lifted its half-year net profit by 4% to PGK 59.7 million, underpinned by a strong capital injection via Papua New Guinea’s inaugural listed corporate bond and a 13% higher interim dividend in local currency.

Gratifii Limited trimmed its net loss to $7.56 million in FY26, supported by a full-year contribution from Club Connect and a $5 million strategic investment in Marketplacer. Despite a 2.5% revenue dip, the company advanced its loyalty platform through acquisitions and AI integration.